SynthesisBMC cancer2020

A meta-analysis of BRF2 as a prognostic biomarker in invasive breast carcinoma.

Stephanie Cabarcas-Petroski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.